Sep 06 2024 This Week in Cardiology

Sep 06 2024 This Week in Cardiology

Feedback on ABYSS and beta-blockers, more ESC recap, including SHAM-PVI, FINEARTS-HF, and RESHAPE HF2 trials are the topics John Mandrola, MD, discusses in today's podcast.

This podcast is intended for healthcare professionals only.

To read a partial transcript or to comment, visit:

https://www.medscape.com/twic

I. Feedback on ABYSS

Setbacks After Stopping Beta-Blockers

https://www.medscape.com/viewarticle/setbacks-after-stopping-beta-blockers-2024a1000fv7

Beta-Blockers Post-MI? No for Me, Even After the ABYSS Trial

https://www.medscape.com/viewarticle/beta-blockers-post-mi-no-me-even-after-abyss-trial-2024a1000fva

  • ABYSS trial https://www.nejm.org/doi/full/10.1056/NEJMoa2404204
  • REDUCE AMI https://www.nejm.org/doi/full/10.1056/NEJMoa2401479
  • QOL paper REDUCE AMI https://doi.org/10.1093/ehjcvp/pvae062
  • Atenolol ED paper 10.1016/j.ehj.2003.08.016

II. SHAM-PVI

  • JAMA SHAM-PVI paper https://jamanetwork.com/journals/jama/article-abstract/2823283
  • Gupta QOL paper https://pubmed.ncbi.nlm.nih.gov/33952593/

III. FINEARTS HF

Finerenone Benefits Heart Failure With Preserved EF

https://www.medscape.com/viewarticle/finerenone-benefits-heart-failure-preserved-ef-2024a1000fza

Topline Finerenone Results Point to Advance in Heart Failure

https://www.medscape.com/viewarticle/topline-finerenone-results-point-advance-heart-failure-2024a1000fq2

  • FINEHEARTS -HF NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2407107
  • FIDELIO-DKD https://www.nejm.org/doi/full/10.1056/NEJMoa2025845
  • FIGARO-DKD https://www.nejm.org/doi/full/10.1056/NEJMoa2110956
  • Why Have We Not Been Able to Demonstrate Reduced Mortality in Patients With HFmrEF/HFpEF? https://doi.org/10.1016/j.jacc.2024.08.033

IV. RESHAPE HF

TEER in Functional MR: Data Deluge, but No Easy Answers

https://www.medscape.com/viewarticle/teer-functional-mr-data-deluge-no-easy-answers-2024a1000fvg

  • Mitra FR https://www.nejm.org/doi/full/10.1056/NEJMoa1805374
  • COAPT https://www.nejm.org/doi/full/10.1056/NEJMoa1806640
  • RESHAPE- HF2 https://www.nejm.org/doi/full/10.1056/NEJMoa2314328
  • RESHAPE Subgroup paper https://doi.org/10.1016/j.jacc.2024.08.027

You may also like:

The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington

Questions or feedback, please contact news@medscape.net

Jaksot(402)

Dec 19 2025 This Week in Cardiology

Dec 19 2025 This Week in Cardiology

The MI paradox of risk scores, the CELEBRATE trial of a new subcutaneous glycoprotein IIb/IIIA inhibitor (with its funny endpoint), the SURPASS CVOT trial, and the bad story of andexanet alfa are the ...

19 Joulu 202535min

Dec 12 2025 This Week in Cardiology

Dec 12 2025 This Week in Cardiology

An elegant study in post-TAVI atrioventricular block, a PSA for my structural colleagues, revascularization in women, and a CTO PCI trial are the topics John Mandrola, MD, discusses in this week's pod...

12 Joulu 202527min

Dec 05 2025 This Week in Cardiology

Dec 05 2025 This Week in Cardiology

Less is more after PCI, the TARGET-FIRST trial, a negative blood pressure trial that is actually positive, aspirin vs OAC for bleeding, AEDs, and Factor XI is not dead yet are the topics discussed by ...

5 Joulu 202529min

Nov 21 2025 This Week in Cardiology

Nov 21 2025 This Week in Cardiology

Listener feedback, huge news in the world of carotid disease with the CREST-2 publication, prasugrel beats ticagrelor again, and a big coffee trial are the topics John Mandrola, MD, discusses in this ...

21 Marras 202529min

Nov 14 2025 This Week in Cardiology

Nov 14 2025 This Week in Cardiology

Listener feedback on the PISCES trial, AHA news (including a big PCSK9i trial), beta-blockers post MI, LAAC, and post-AF ablation OAC use are the topics John Mandrola, MD, discusses in this week's pod...

14 Marras 202536min

Nov 07, 2025 This Week in Cardiology

Nov 07, 2025 This Week in Cardiology

Listener feedback on non-culprit PCI in STEMI, a major cardiac result in patients on hemodialysis, news on GLP-1 agonists, a dubious stroke trial, and an AHA preview are the topics John Mandrola, MD, ...

7 Marras 202532min

Oct 31 2025 This Week in Cardiology

Oct 31 2025 This Week in Cardiology

Four pillars of cardiology today, stable coronary artery disease, severe aortic stenosis, the evaluation of chest pain, and best therapies for atrial fibrillation are the topics John Mandrola, MD, dis...

31 Loka 202531min

Oct 24 2025 This Week in Cardiology

Oct 24 2025 This Week in Cardiology

The PREVENT score in hypertension, GLP-1 mechanism of action in cardiovascular disease, CAD type and statin benefit, and the problem with hospitalization endpoints in HF trials are the topics John Man...

24 Loka 202530min

Suosittua kategoriassa Tiede

rss-poliisin-mieli
rss-mita-tulisi-tietaa
tiedekulma-podcast
rss-tiedetta-vai-tarinaa
rss-lihavuudesta-podcast
hippokrateen-vastaanotolla
utelias-mieli
koodikahvit
rss-astetta-parempi-elama-podcast
rss-tervetta-skeptisyytta
university-of-eastern-finland
radio-antro
rss-duodecim-lehti
rss-duokkari-ekstra
rss-metsantuntijat-podcast
rss-ylistys-elaimille
rss-sosiopodi
rss-kasvikutsut
rss-miljonaarien-tasavalta